Results for Regeneration

Dr. Song works to elucidate the cellular and molecular basis governing the formation, maintenance, and function of neural circuits under physiological and pathological conditions, using both Drosophila and mammalian models.

Dr. Sengupta is a neonatologist and physician scientist with a long-standing interest in lung health. She studies the mechanisms of circadian regulation of lung inflammation, injury, and repair; and the effect of early life exposures on development and function of pulmonary circadian networks in adulthood.

Dr. Hamilton studies intestinal epithelial cells and how they help maintain human health. Although there is a great deal understood about how these cells function, little is known about how they behave during disease. Dr. Hamilton focuses on defining new mechanisms in regenerative medicine, inflammatory bowel disease, and colorectal cancer.

Dr. Gottardi leads the Bioengineering and Biomaterials (Bio²) lab, collaborating on clinical and research efforts to offer engineering solutions for pediatric health, primarily treatments for airway disorders. Dr. Gottardi researches mechanisms of laryngotracheal pathologies, applies tissue engineering to improve pediatric conditions, develops new devices, and formulates controlled drug delivery systems to treat and improve patients’ lives.

Dr. Grinspan's research program focuses on oligodendrocytes, cells of the central nervous system that synthesize the myelin sheath required for transmission of nervous impulses. Her research seeks to understand the signaling pathways that regulate oligodendrocyte maturation and how they are perturbed in diseases such as multiple sclerosis, HIV, and perinatal white matter injury.

Kevin Bryan is a sophomore undergraduate student at the University of Pennsylvania pursuing a degree in Neuroscience. He is interested in the mechanisms regulating neural regeneration, and the world of neurodegenerative disorders fascinates him. He plans to go to medical school in the future.

Dr. Wang is involved in several projects that aim to investigate the pathological function of the novel protein variants identified from neurodevelopmental patients and to explore how to promote functional axon regeneration after traumatic brain injury or neurodegeneration.

Dr. Will Towler joined the Liao Lab in October 2022 to elucidate mechanisms guiding craniofacial asymmetry, as in hemifacial microsomia, with the goal to apply gene therapy solutions to craniofacial research.

Piotr Jung is a postdoctoral fellow in the Wolpaw Lab focused on modeling lineage heterogeneity in neuroblastoma. Jung is interested in how three-dimensional culture methods impact cell state.